NCT04667780View on ClinicalTrials.gov

Study to Investigate the Treatment Effect of Colchicine in Patients With COVID-19

PHASE3CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

July 9, 2021

Study Completion Date

July 9, 2021

Conditions
COVID-19
Interventions
DRUG

Colchicine

Colchicine tablet 0.5 mg

DRUG

Standard COVID-19 care

As per the hospital guidelines

Trial Locations (1)

22010

Ayub Teaching Hospital, Abbottabad

All Listed Sponsors
collaborator

Universidad de Murcia

OTHER

lead

Ayub Teaching Hospital

OTHER

NCT04667780 - Study to Investigate the Treatment Effect of Colchicine in Patients With COVID-19 | Biotech Hunter | Biotech Hunter